Why 2026 Is the Best Time in a Decade to Sell a Med Spa
Three market forces are converging in 2026 to make this the strongest seller's market for med spas in a decade. Here's what is driving them and how long the window stays open.
The three forces converging in 2026
Every real estate cycle, every industry rollup, every M&A wave has its window. The med spa transaction market is in one now. Three specific forces are converging in 2026, and they do not stay converged for long.
If you are a med spa owner within five years of a potential exit, you should understand these forces before you sign your next lease renewal.
Force 1: COVID-era lease renewals hitting all at once
Roughly 35% of med spas in the U.S. were opened between 2020 and 2022. Standard commercial leases run 5-7 years. The entire cohort is up for renewal now.
Owners are forced into a decision they would rather delay: sign a new 5-year commitment or exit. Historically, when this many owners hit the same decision at the same time, sale processes surge.
The compounding effect: even owners who were not thinking about selling six months ago are being pulled into the market by the lease decision. Buyers know this. The best-prepared sellers are already inside the process.
Force 2: Private capital is actively rolling up aesthetics
Every quarter, another private equity sponsor declares an aesthetics thesis. Family offices are building services-focused portfolios. Strategic operators are actively hunting bolt-ons.
The buyer side of the market has never been deeper. Real numbers:
- Over 40 announced med spa platform investments in 2025
- More than $2B of dry powder committed to aesthetics rollups
- Bolt-on transaction velocity up 60% year over year
Result: sellers with clean books have their pick of buyers. Sellers who are unprepared still have offers on the table.
Force 3: Multiples are stratifying, not compressing
Contrary to what you would expect in a saturated market, med spa multiples haven't compressed in 2026. They have stratified.
Well-run, multi-provider spas with recurring revenue are trading at premium multiples (7-9x adjusted EBITDA). Solo-provider spas without membership programs are trading at compressed multiples (3.5-4.5x).
This means the "get valued and start prepping" work matters more, not less, in 2026. A spa that would have sold at 5x in 2022 might sell at 7x in 2026 with the right preparation, or at 3.5x without it.
What happens when the window closes
Windows do not close because of any single event. They close because:
- The lease renewal cohort works through the decision (12-18 months from now)
- Private capital shifts thesis to the next fragmented industry
- Public multiples compress and everyone rerates
Historically, aesthetics M&A cycles run 3-5 years. We are 2 years into this one. The strongest window is now.
What owners should do in 2026
If you are within 12 months of a potential sale:
- Get a valuation to know your current defensible range.
- Start the clean-up sprint on the 3-5 drivers that will move your multiple.
- Do not sign a long-term lease renewal without modeling the deal impact.
If you are 12-24 months out:
- Build the membership program if you do not have one.
- Reduce provider concentration by hiring or contracting additional injectors.
- Clean the books so future diligence goes smoothly.
If you are 24+ months out:
- Track your metrics monthly.
- Build the operating rhythm of a business, not a practice.
- Watch the buyer side of the market through industry coverage.
What owners should NOT do
- Panic-sell into a lease deadline.
- Sign with a generic broker who lists you between a laundromat and a gas station.
- Wait for a "better market" that likely will not come.
The bottom line
The confluence of forces is unusual. In our experience running med spa transactions, we have not seen a stronger seller's market in a decade. Whether or not you sell in 2026, this is the year to understand your number.